Alan Moss MD @alanmoss.bsky.social · 05/02/2025Manipulating the #microbiome to treat hypertension; “L. plantarum CCFM639 supplementation reduces BPs in subjects with newly diagnosed hypertension.” 010
Alan Moss MD @alanmoss.bsky.social · 05/02/2025Full house for Day 1 of #IUSCAN #IBUS intestinal US course @CCCongress2025 #AGA #CrohnsColitisFoundation 110
Alan Moss MD @alanmoss.bsky.social · 22/01/2025Really excited to see the 🇪🇺Innovative Health Initiative (IHI) fund the first EU interception trial for people at risk of developing #CrohnsDisease 🚀🌖 www.intercept-ihi.euintercept-ihi.euHome | INTERCEPTVerification and validation of a biomarker panel that identifies individuals at high risk to develop Crohn’s Disease allowing INTERCEPTION of full-blown disease development. 040
Reposted by Alan Moss MDIBD Doctor @ibddoctor.bsky.social · 10/01/2025#CCC - Feb 6 Cells and Interactions II T cell Regulation in Intestinal Tissues Under Homeostasis and Inflammation Jeremy A. Goettel Fibroblasts in Intestinal Inflammation Roni Nowarski Enteric Nervous System Regulation of Intestinal Inflammation Christoph Thaiss Register crohnscolitiscongress.orgcrohnscolitiscongress.orgHome 2025Join colleagues across the entire spectrum of clinical care and science at the premier conference on inflammatory bowel disease (IBD). 021
Reposted by Alan Moss MDIBD Pro @ibdpro.bsky.social · 03/01/2025🌟 Calling all #GIFellows! Apply now for the 2025–26 Visiting IBD Observership Program! ✅ Gain experience at a leading #IBD center. ✅ Accelerate your IBD career ✅ Access specialized education ⏳ Slots limited, apply today! #VIBD #IBDPro bit.ly/41YXdxCbit.ly2025-2026 Visiting IBD Observership Program ApplicationTake this survey powered by surveymonkey.com. Create your own surveys for free. 023
Alan Moss MD @alanmoss.bsky.social · 17/12/2024More #TL1A inhibitor data this week, with results of duvakitug mAB for #UlcerativeColitis; and #CrohnDisease Sanofi lnkd.in/ejZrZyvU This class of drug has potential to reverse fibrosis; www.mucosalimmunology.org/article/S193...mucosalimmunology.orgDEFINE_ME 020
Alan Moss MD @alanmoss.bsky.social · 13/12/2024“Takeda has decided to pull its Alofisel from the EU market as a treatment for complex anal fistulas in Crohn’s disease.” More work needed to find new options for Crohn’s fistulas. #IBDsky www.takeda.com/newsroom/sta...takeda.comTakeda Update on Alofisel (darvadstrocel)Takeda voluntarily withdraws marketing authorization of Alofisel (darvadstrocel) in the European Union 170
Alan Moss MD @alanmoss.bsky.social · 23/11/2024Trying to figure out why I’ve gotten so many Dutch followers in the last 24 hrs 🤔 “This is not the Moss you’re looking for”media.tenor.coman old man with a beard says " these aren t the droids you 're looking for "ALT: an old man with a beard says " these aren t the droids you 're looking for " 160
Alan Moss MD @alanmoss.bsky.social · 21/11/2024Early bird rate for #CCCongress25 ends on Wednesday ⏰ 🐐 @umamahadevanibd.bsky.social keynote on IBD & 🤰 👩🏫 #IBD A-Z 💪 Surgery prehabilitation 🚨Ultrasound training course with #IUSCAN #IBUS @edelblumlab.bsky.social #AGA crohnscolitiscongress.org 184
Alan Moss MD @alanmoss.bsky.social · 21/11/2024“Dear Prof Moss It is with immense pleasure and honour that I communicate with you. It is always a pleasure to read your excellent articles and discoveries. You are truly an esteemed scientist and professor. I could not resist to ask such an expert..” Please stop, I accept...🎣 110
Alan Moss MD @alanmoss.bsky.social · 18/11/2024Delighted to confirm that #IUSCAN & #IBUS will host their first module 1 ultrasound training for GIs at a U.S. #IBD meeting at #CCCongress25 🔥 #CrohnsColitisFoundation #AGA lu.ma/fyqhs5xelu.maIBUS Hybrid Module 1 Workshop: Crohn's & Colitis Congress 2025 · LumaIBUS Hybrid Module 1 Workshop: Crohn's Colitis Congress 2025 To apply for this workshop, please visit the IBUS application page here. Information The 6th IBUS… 030
Alan Moss MD @alanmoss.bsky.social · 18/11/2024I've moved over from X; expect to resume posts on #IBD, #GI, #immunology shortly 👍 090